EGFR and cancer: This is mainly because the METTL1/WDR4 complex can increase the m7G modification of a subset of tRNAs, thereby reducing ribosomal pausing and increasing the translation efficiency of cancer-promoting mRNAs such as EGFR, which drives cancer development (14–16).